Self-funded employers control healthcare risk and are increasingly moving beyond traditional network models to directly contract with high-performing domestic and international providers. As healthcare costs continue to rise, particularly in complex surgeries and specialty pharmaceuticals, employers and their advisors are seeking structural solutions that deliver measurable savings without compromising quality or employee experience.
‍

This executive session is designed for employers, brokers, and benefits consultants who are focused on transforming healthcare spend rather than making incremental adjustments. We will examine how leading organizations are building direct contracting strategies, leveraging domestic and global Centers of Excellence, aligning incentives across stakeholders, and implementing scalable frameworks that reduce total cost of care while improving outcomes and satisfaction.
‍

• How self-funded employers can reduce 50 to 80 percent on complex surgeries and specialty drugs
• Domestic versus global Centers of Excellence and when to deploy each model
• Designing bundled pricing structures with outcome guarantees
• Risk-sharing models that align employer, provider, and consultant incentives
• Specialty pharmacy arbitrage and cross-border biologics strategies
• Protecting employee experience while reducing total cost of care
• The broker’s role in structuring, negotiating, and scaling enterprise programs
• Legal, fiduciary, and plan design considerations for domestic and international deployment
• Implementation strategies that move from pilot programs to scalable enterprise solutions

This discussion focuses on moving from incremental cost containment to structural cost transformation.

‍